'Equitable distribution': Covax says Serum bound to supply virus vaccines

India could resume vaccine exports by June, the firm's chief executive, Adar Poonawalla, told media this week

 The Serum Institute of India (SII) is legally compelled to ship coronavirus vaccine to global vaccine sharing facility COVAX, its co-lead Gavi has told Reuters, a provision that could complicate the firm's efforts to boost domestic supplies.
 

India, where infections have surged to 13.06 million, suspended all major exports of vaccines last month to fill demand at home, forcing the world's biggest vaccine maker to divert nearly all its production to the domestic market.
 

"The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies," a Gavi spokeswoman